Citations

Mayo Clinic

Showing 10 of 108522 citations.

Perineural spread of malignant melanoma from the mandible to the brachial plexus: case report
Restrepo, Carlos E., Spinner, Robert J. , Howe, B. Matthew, Jentoft, Mark E. , Markovic, Svetomir N. , Lachance, Daniel Honore

Journal of Neurosurgery | January 23, 2015 | Volume: 122 | Issue: 4 | Pages: 784-790

10.3171/2014.12.jns14852 | PMID 25614946 Get It

Perineural spread is a well-known mechanism of dissemination of head and neck malignancies. There are few reports of melanoma involving the brachial plexus in the literature. To their knowledge, the authors report the first known case of perineural spread of malignant melanoma to the brachial plexus. Clinicoradiological and anatomopathological correlation is presented, highlighting the importance of peripheral nerve communications in perineural spread.
Gestational Diabetes Mellitus Impairs Fetal Endothelial Cell Functions Through a Mechanism Involving MicroRNA-101 and Histone Methyltransferase Enhancer of Zester Homolog-2
Floris, Ilaria , Descamps, B, Vardeu, Antonella, Mitić, Tijana , Posadino, Anna Maria , Shantikumar, Saran , Sala-Newby, Graciela, Capobianco, Giampiero , Mangialardi, Giuseppe, Howard, Lynsey, Dessole, Salvatore , Pintus, Gianfranco , Emanueli, Costanza , Descamps, Betty, Capobianco, Gianpiero, Urrutia, Raúl , Sala‐Newby, Graciela B.

Arteriosclerosis, Thrombosis, and Vascular Biology | January 23, 2015 | Volume: 35 | Issue: 3 | Pages: 664-674

10.1161/atvbaha.114.304730 | PMID 25614281 Get It

Objective— Gestational diabetes mellitus (GDM) produces fetal hyperglycemia with increased lifelong risks for the exposed offspring of cardiovascular and other diseases. Epigenetic mechanisms induce long-term gene expression changes in response to in utero environmental perturbations. Moreover, microRNAs (miRs) control the function of endothelial cells (ECs) under physiological and pathological conditions and can target the epigenetic machinery. We investigated the functional and expressional effect of GDM on human fetal ECs of the umbilical cord vein (HUVECs). We focused on miR-101 and 1 of its targets, enhancer of zester homolog-2 (EZH2), which trimethylates the lysine 27 of histone 3, thus repressing gene transcription. EZH2 exists as isoforms α and β. Approach and Results— HUVECs were prepared from GDM or healthy pregnancies and tested in apoptosis, migration, and Matrigel assays. GDM-HUVECs demonstrated decreased functional capacities, increased miR-101 expression, and reduced EZH2- β and trimethylation of histone H3 on lysine 27 levels. MiR-101 inhibition increased EZH2 expression and improved GDM-HUVEC function. Healthy HUVECs were exposed to high or normal d -glucose concentration for 48 hours and then tested for miR-101 and EZH2 expression. Similar to GDM, high glucose increased miR-101 expression. Chromatin immunoprecipitation using an antibody for EZH2 followed by polymerase chain reaction analyses for miR-101 gene promoter regions showed that both GDM and high glucose concentration reduced EZH2 binding to the miR-101 locus in HUVECs. Moreover, EZH2-β overexpression inhibited miR-101 promoter activity in HUVECs. Conclusions— GDM impairs HUVEC function via miR-101 upregulation. EZH2 is both a transcriptional inhibitor and a target gene of miR-101 in HUVECs, and it contributes to some of the miR-101-induced defects of GDM-HUVECs.
Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma
Larsen, Brandon T. , Grys, Thomas E. , Vikram, Holenarasipur R. , Colby, Thomas V. , Smith, Maxwell L. , Vikram, Holenarasipur R. , Grys, Thomas E

International Journal of Surgical Pathology | January 23, 2015 | Volume: 23 | Issue: 3 | Pages: 189-195

10.1177/1066896914567332 | PMID 25614462 Get It

Intravesical instillation of Bacillus Calmette-Guérin (BCG) is a mainstay of adjunctive therapy for superficial bladder cancer. Disseminated BCG infection (“BCG-osis”) after this therapy is rare and potentially life-threatening; only isolated case reports detail the histopathologic findings thereof, few of which had a diagnosis confirmed by molecular testing. We report 3 additional cases of BCG-osis complicating BCG therapy, all confirmed by cultures and molecular assays, including the first cases of wedge biopsy-confirmed BCG pneumonia and BCG olecranon bursitis. When suggested by a relevant clinical history, recognition of randomly distributed granulomas in any organ should prompt consideration of BCG-osis and liberal performance of AFB stains, aided by targeted molecular assays. Physicians should maintain a high index of suspicion when miliary infiltrates arise after intravesical BCG instillation, and close multidisciplinary communication is essential. Pathologist awareness of this rare cause of granulomatous inflammation aids recognition of BCG-osis and facilitates prompt initiation of antimycobacterial therapy.
If This Then That: An Introduction to Automated Task Services
Hoy, Matthew B.

Medical Reference Services Quarterly | January 22, 2015 | Volume: 34 | Issue: 1 | Pages: 98-103

10.1080/02763869.2015.986796 | PMID 25611444 Get It

Relationship between hippocampal atrophy and neuropathology markers: A 7T MRI validation study of the EADC‐ADNI Harmonized Hippocampal Segmentation Protocol
Apostolova, Liana G. , Zarow, Chris, Biado, Kristina, Hurtz, Sona, Boccardi, Marina , Honarpisheh, Hedieh, Blanken, Anna E., Brook, Jenny , Tung, Spencer, Kraft, Emily, Lo, D.C.W. , Ng, Denise , Alger, Jeffry R. , Vinters, Harry V. , Bocchetta, Martina , Duvernoy, Henri M., Jack, Clifford R. , Frisoni, Giovanni B. , Segmentation, EADC‐ADNI Working Group on the Harmonized Protocol for Manual Hippocampal, Bartzokis, George, Csernansky, John G., deToledo‐Morrell, Leyla, Lehéricy, Stéphane , Malykhin, Nikolai , Pantel, Johannes, Pruessner, Jens C. , Watson, Craig, Boccardi, Marina , Frisoni, Giovanni B. , Somme, Johanne Hatteland , Segmentation, EADC‐ADNI Working Group on the Harmonized Protocol for Manual Hippocampal, Leon, Mony J. de , Killiany, Ronald , Soininen, Hilkka S. , Jack, Clifford R , Bocchetta, Martina

Alzheimer's & Dementia | January 22, 2015 | Volume: 11 | Issue: 2 | Pages: 139-150

10.1016/j.jalz.2015.01.001 | PMID 25620800 Get It

AbstractObjectiveThe pathologic validation of European Alzheimer's Disease Consortium Alzheimer’s Disease Neuroimaging Initiative Center Harmonized Hippocampal Segmentation Protocol (HarP).MethodsTemporal lobes of nine Alzheimer's disease (AD) and seven cognitively normal subjects were scanned post‐mortem at 7 Tesla. Hippocampal volumes were obtained with HarP. Six‐micrometer‐thick hippocampal slices were stained for amyloid beta (Aβ), tau, and cresyl violet. Hippocampal subfields were manually traced. Neuronal counts, Aβ, and tau burden for each hippocampal subfield were obtained.ResultsWe found significant correlations between hippocampal volume and Braak and Braak staging (ρ = −0.75, P = .001), tau (ρ = −0.53, P = .034), Aβ burden (ρ = −0.61, P = .012), and neuronal count (ρ = 0.77, P < .001). Exploratory subfield‐wise significant associations were found for Aβ in Cornu Ammonis (CA)1 (ρ = −0.58, P = .019) and subiculum (ρ = −0.75, P = .001), tau in CA2 (ρ = −0.59, P = .016), and CA3 (ρ = −0.5, P = .047), and neuronal count in CA1 (ρ = 0.55, P = .028), CA3 (ρ = 0.65, P = .006), and CA4 (ρ = 0.76, P = .001).ConclusionsThe observed associations provide pathological confirmation of hippocampal morphometry as a valid biomarker for AD and pathologic validation of HarP.
Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists
Lester, Rachael, Lu, Ying , Tung, Jeanne

Journal of Pediatric Gastroenterology and Nutrition | January 22, 2015 | Volume: 61 | Issue: 1 | Pages: 47-51

10.1097/mpg.0000000000000730 | PMID 25611033 Get It

ABSTRACTObjectives:We aimed to determine vaccination practices of pediatric gastroenterologists, as well as barriers to following immunization guidelines in patients with inflammatory bowel disease.Methods:Institutions listed in the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition clinical research registry and/or ImproveCareNow were contacted. A total of 657 physicians from 129 institutions were asked to complete a 16‐question electronic survey.Results:A total of 178 physicians (27.1%) responded, of whom 55% were male and 83.1% practiced in an academic setting. A total of 11 physicians (6.2%) do not routinely assess vaccination status, whereas 63.5% assess at the time of diagnosis, 29.8% at “well” visits, and 44.4% before initiating immunosuppression. At diagnosis, 51.1% verbally inquire about immunization status, 30.9% obtain records, and 9.0% obtain serology.The influenza (78%), hepatitis B (84%), and varicella (82%) vaccines were most frequently assessed. Fewer than 55.5% of physicians reviewed other vaccines. Physicians using a reminder mechanism were more likely to review immunizations at established visits (41.1% vs 20.8%), and before transfer to an adult gastroenterologist (14.4% vs 2.6%). Lack of coordination of care with primary care practitioners (41%), poor access to immunization records (36%), and inability to offer vaccinations in their immediate area (55%) are barriers to vaccination. Only 28% believed that primary care practitioners were solely responsible for immunizations.Conclusions:There is practice variation among pediatric gastroenterologists in assessment of immunizations in patients with inflammatory bowel disease, including the specific vaccines assessed, and timing and method of assessment. Inability to coordinate care, access immunization records, and offer vaccines through their medical practice are barriers to adhering to immunization guidelines.
Turnaround Time for Large or Complex Specimens in Surgical Pathology: A College of American Pathologists Q-Probes Study of 56 Institutions
Volmar, Keith E., Souers, Rhona J., Karcher, Donald S. , Nakhleh, Raouf E. , Idowu, Michael O.

Archives of Pathology & Laboratory Medicine | January 22, 2015 | Volume: 139 | Issue: 2 | Pages: 171-177

10.5858/arpa.2013-0671-cp | PMID 25611100 Get It

Context Turnaround time (TAT) for large or complex surgical pathology specimens is an indicator of efficiency in anatomic pathology and may affect coordination of patient care. Objective To establish benchmarks for TAT and to identify practice characteristics that may influence TAT. Design Participants in a 2012 Q-Probes quality improvement program of the College of American Pathologists retrospectively reviewed all surgical pathology cases from the prior 6 months to identify up to 50 cases coded as Current Procedural Terminology (CPT) code 88307 (excluding biopsies) or 88309. Participants reported the times and dates of accessioning and final sign-out. Results A total of 56 institutions reported on 2763 large or complex cases, which included 70% with CPT code 88307 and 30% with CPT code 88309. Cases requiring special handling comprised 51.5%, and 48.5% were routine. Among all institutions the median TAT was 2.72 calendar days (10th–90th percentile range, 6.23–1.22 days). Longer TAT occurred in governmental institutions (median, 6.06 versus 2.13 days; P &lt; .001) and in institutions that mandate overnight fixation for some specimen types (median, 3.83 versus 2.07 days; P = .03). Longer TAT was associated with CPT code 88309 (median, 3.99 versus 2.82 days; P &lt; .001), special handling (median, 4.13 versus 1.94 days; P &lt; .001), frozen section (median, 3.38 versus 2.92 days; P &lt; .001), radical cancer resection (P &lt; .001), and malignant cases (P &lt; .001). Turnaround time was not significantly affected by either pathology training programs or routine weekend sign-out. Conclusion This study provides benchmark data for TAT in large or complex surgical pathology specimens. Turnaround time was good overall, but the range among participating institutions was wide.
Genetic susceptibility to diffuse large B‐cell lymphoma in a pooled study of three Eastern Asian populations
Bassig, Bryan A. , Au, Wing‐Yan, Sangrajrang, Suleeporn , Tse, Jovic, Berndt, Sonja I. , Zheng, Tongzhang, Pornsopone, Pattarapong, Lee, Je‐Jung , Kim, Hyeoung‐Joon , Skibola, Christine F., Vijai, Joseph , Burdette, Laurie , Brennan, Paul , Liang, Raymond , Lan, Qing , Rothman, Nathaniel , Cerhan, James R. , Kim, Hee Nam , Hu, Wei , Zhang, Heping , Yeager, Meredith , Shin, Min‐Ho , Chanock, Stephen Jacob , Rothman, Nathaniel , Joseph, Vijai

European Journal of Haematology | January 22, 2015 | Volume: 95 | Issue: 5 | Pages: 442-448

10.1111/ejh.12513 | PMID 25611436 Get It

AbstractObjectivesDiffuse large B‐cell lymphoma (DLBCL) is an aggressive subtype of non‐Hodgkin lymphoma (NHL) and is the most common NHL subtype diagnosed worldwide. The first large‐scale genome‐wide association study (GWAS) of DLBCL with over 4000 cases conducted among individuals of European ancestry recently identified five independent SNPs that achieved genome‐wide significance, and two SNPs that showed a suggestive association with DLBCL risk.MethodsTo evaluate whether Eastern Asians and individuals of European ancestry share similar genetic risk factors for this disease, we attempted to replicate these GWAS findings in a pooled series of 1124 DLBCL cases and 3596 controls from Hong Kong, South Korea, and Thailand.ResultsThree of the five genome‐wide significant SNPs from the DLBCL GWAS were significantly associated with DLBCL in our study population, including the top finding from the GWAS, EXOC2 rs116446171, which achieved genome‐wide significance in our data (per allele OR = 2.04, 95% CI = 1.63–2.56; ptrend = 3.9 × 10−10). Additionally, we observed a significant association with PVT1 rs13255292 (per allele OR = 1.34, 95% CI = 1.19–1.52; ptrend = 2.1 × 10−6), which was the second strongest finding in the GWAS, and with HLA‐B rs2523607 (per allele OR = 3.05, 95% CI = 1.32–7.05; ptrend = 0.009).ConclusionsOur study, which provides the first evaluation in Eastern Asians of SNPs definitively associated with DLBCL risk in individuals of European ancestry, indicates that at least some of the genetic factors associated with risk of DLBCL are similar between these populations.
Migraine and the vascular system: Much has been learned but still a long way to go
Kurth, Tobias , Dodick, David W. , Kurth, Tobias

Cephalalgia | January 22, 2015 | Volume: 35 | Issue: 2 | Pages: 83-84

10.1177/0333102414566050 | PMID 25613014 Get It

Effectiveness in acute migraine treatment
Mack, Kenneth J. , Digre, Kathleen B. , Digre, Kathleen

Neurology | January 22, 2015 | Volume: 84 | Issue: 7 | Pages: 641-642

10.1212/wnl.0000000000001273 | PMID 25609759 Get It